These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33299663)

  • 1. Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy.
    Tremblay ML; O'Brien-Moran Z; Rioux JA; Nuschke A; Davis C; Kast WM; Weir G; Stanford M; Brewer KD
    Oncoimmunology; 2020 Nov; 9(1):1851539. PubMed ID: 33299663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine.
    Tremblay ML; Davis C; Bowen CV; Stanley O; Parsons C; Weir G; Karkada M; Stanford MM; Brewer KD
    Magn Reson Med; 2018 Jul; 80(1):304-316. PubMed ID: 29193231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of highly activated, antigen-specific tumor-infiltrating CD8
    Vila-Leahey A; MacKay A; Portales-Cervantes L; Weir GM; Merkx-Jacques A; Stanford MM
    Oncoimmunology; 2020 Jun; 9(1):1782574. PubMed ID: 32923145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model.
    Dirk BS; Weir G; Quinton T; Hrytsenko O; Stanford MM
    Sci Rep; 2021 Feb; 11(1):4502. PubMed ID: 33627686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Magnetotactic Bacteria as an MRI Contrast Agent for In Vivo Tracking of Adoptively Transferred Immune Cells.
    Nuschke A; Sobey-Skelton C; Dawod B; Kelly B; Tremblay ML; Davis C; Rioux JA; Brewer K
    Mol Imaging Biol; 2023 Oct; 25(5):844-856. PubMed ID: 37715090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner.
    Xu Y; Wu C; Zhu W; Xia C; Wang D; Zhang H; Wu J; Lin G; Wu B; Gong Q; Song B; Ai H
    Biomaterials; 2015 Jul; 58():63-71. PubMed ID: 25941783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.
    Crisci E; Fraile L; Novellas R; Espada Y; Cabezón R; Martínez J; Cordoba L; Bárcena J; Benitez-Ribas D; Montoya M
    Mol Immunol; 2015 Feb; 63(2):343-54. PubMed ID: 25282042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell density quantification with TurboSPI: R
    O'Brien-Moran Z; Bowen CV; Rioux JA; Brewer KD
    MAGMA; 2020 Aug; 33(4):469-481. PubMed ID: 31872356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide.
    Mou Y; Hou Y; Chen B; Hua Z; Zhang Y; Xie H; Xia G; Wang Z; Huang X; Han W; Ni Y; Hu Q
    Int J Nanomedicine; 2011; 6():2633-40. PubMed ID: 22114494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using lymph node swelling as a potential biomarker for successful vaccination.
    Brewer KD; DeBay DR; Dude I; Davis C; Lake K; Parsons C; Rajagopalan R; Weir G; Stanford MM; Mansour M; Bowen CV
    Oncotarget; 2016 Jun; 7(24):35655-35669. PubMed ID: 27232944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.
    DeBay DR; Brewer KD; LeBlanc SA; Weir GM; Stanford MM; Mansour M; Bowen CV
    Mol Ther Methods Clin Dev; 2015; 2():15048. PubMed ID: 26730395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy.
    Fransen MF; Schoonderwoerd M; Knopf P; Camps MG; Hawinkels LJ; Kneilling M; van Hall T; Ossendorp F
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
    Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S
    J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner.
    Joo HJ; Kim HS; Choi YS; Kim H; Kim SJ; Moon WK
    NMR Biomed; 2012 Apr; 25(4):570-9. PubMed ID: 22009917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice.
    Baumjohann D; Hess A; Budinsky L; Brune K; Schuler G; Lutz MB
    Eur J Immunol; 2006 Sep; 36(9):2544-55. PubMed ID: 16909432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes.
    Reyes AF; Goldusky J; Bhimalli P; Marzo AL; Schneider JR
    J Immunol Methods; 2022 Jun; 505():113253. PubMed ID: 35358495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.